|
For Immediate Release
March 22, 1995
GETTING TO THE HEART OF CHAOS: RESEARCHERS BEGIN HUMAN
TRIALS OF TECHNIQUE TO CONTROL ATRIAL FIBRILLATION
A team of researchers from the Georgia Institute of Technology and Emory
University has begun limited human testing on an experimental technique
that may help control irregular cardiac rhythms by altering chaotic patterns
in the electrical signals controlling the heart.
If successful, the technique could lead to development of a new type
of implantable device that would be smaller and apply less electrical
energy than the defibrillators now used to correct the erratic heartbeat
of atrial fibrillation.
"We will be trying to actively put signals into the human atrium to see
if we can achieve partial control of a heart undergoing atrial fibrillation,"
explained Dr. William L. Ditto, a physicist in Georgia Tech's Applied
Chaos Laboratory. "If the technique is successful, we would try the
engineering challenge of miniaturizing the equipment to make it implantable."
Ditto described the research program at a meeting of the American Physical Society March 22 in San Jose,
CA.
Existing defibrillators use large electrical shocks to overwhelm harmful
cardiac rhythms and return the heart to a normal pattern. The technique
being developed by Ditto, Emory University cardiologist Dr. Jonathan J.
Langberg and Dr. Mark L. Spano from the Naval Surface Warfare Center will
apply small electrical signals to the heart at carefully chosen points
in the heartbeat cycle. The researchers believe the small signals will
encourage the heart itself to correct the irregularities.
"The analogy would be judo," Ditto explained. "If a very large person
attacks you, you could try to overpower him if you had enough energy --
which is typical of the way we now do defibrillation -- or you could try
to make their violence work in your favor. We are hoping this technique
will use the energy of the harmful behavior to move the heart back into
good behavior. Rather than fight the chaotic pattern, we want to have
the chaos do most of the work for us."
Starting this spring, Ditto, Langberg and Spano will study and attempt
to treat atrial fibrillation in 10-20 patients by administering control
signals through an electrode threaded into their hearts. If successful,
they may be able to apply the technique to ventricular fibrillation.
"Atrial fibrillation is the most common arrhythmia requiring treatment
intervention, affecting five percent of all individuals over 60 years
of age," said Langberg, professor of medicine (cardiology) and director
of electrophysiology at Emory University
School of Medicine.
"The rhythm disorder may cause palpitation, shortness of breath and weakness,
and may predispose those affected to blood clots and stroke," Langberg
added. "Medications are incompletely effective and associated with frequent
and sometimes dangerous side effects. A chaos control pacemaker would
be a very useful option for treatment of patients with episodic atrial
fibrillation."
At the same time the study of atrial fibrillation is beginning, Ditto
and Spano are collaborating with University of Alberta cardiologist Dr.
Frank Witkowski to study chaos control of ventricular fibrillation in
animal hearts. Plans also call for a study of ventricular fibrillation
in diseased human hearts removed from transplant patients.
In August, Ditto was part of a team reporting early success at altering
chaotic patterns of brain activity similar to those associated with certain
types of epileptic seizures. That work could one day provide a new option
for severe cases of epilepsy that now can only be treated with brain surgery.
That research team, which included Spano and Dr. Steven J. Schiff from
the Children's National Medical Center, studied three separate techniques
for altering chaotic patterns observed in slices of tissue from the hippocampal
section of the rat brain. Published August 25 in the journal Nature,
the report also described the application of "anticontrol" techniques
for maintaining chaotic patterns that appear to be helpful in normal brain
activity.
"In typical control, we try to take a chaotic system that is highly irregular
and make it regular," Ditto explained. "In the brain, we tried to take
a system that is pathologically regular and kick it back into a more healthy
chaotic state. The idea is that a small amount of chaos may be good for
you while a large amount may be very bad."
Anticontrol may also be applied to the heart, where researchers speculate
that some irregularity between beats is necessary to maintain healthy
rhythms.
As in other work, the chaos researchers tested "anticontrol" in mechanical
systems before attempting to apply it to biological systems. While there
are many obvious differences, the similarities have contributed to rapid
advances in both physics and biology.
"The interplay between physics and biology has been very fruitful for
us," Ditto added. "You really can reverse engineer techniques from biology
and apply them to engineering."
One of the primary missions of Ditto's Applied Chaos Lab is to facilitate
the crossover of important technologies between medicine, biology and
physics. One such example is an ongoing effort to use chaos control to
encode information into brain tissue and electronic neural networks in
an attempt to both better understand the working of the human brain and
to make electronics as flexible as biological systems.
In mechanical systems, new research shows that chaos can be maintained
by irregularly applying stimuli on the average of once every thousand
seconds. The key is knowing exactly when to apply the stimulus, and chaos
researchers have established analytical techniques for determining that.
The chaos research has been sponsored by the U.S. Office of Naval Research, by
the pacemaker company Medtronics, Inc., and by the Georgia Institute of
Technology. Patented techniques for cardiac control have been licensed
to Medtronics and a company called Control Dynamics, Inc., that has been
formed by Ditto and others to exploit and commercialize chaos control
and antichaos control techniques in biology, medicine, electronics and
engineering.
RESEARCH NEWS AND PUBLICATIONS OFFICE
Georgia Institute of Technology
75 Fifth Street, N.W., Suite 100
Atlanta, Georgia 30308
MEDIA RELATIONS CONTACTS:
John Toon (404-894-6986);
Internet: john.toon@edi.gatech.edu;
FAX: (404-894-4545);
WRITER: John Toon
|